SCHEMBL3495355

SCHEMBL3495355

CC(=O)C1=C(O)c2ccccc2S(=O)(=O)N1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.66
PTGS1 P23219 3/20 0.59
PTGS2 P35354 3/20 0.59
KDM4E B2RXH2 2/20 0.59
USP2 O75604 2/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
ALOX15 P16050 1/20 0.59
NFKB1 P19838 1/20 0.59
CYP2C19 P33261 1/20 0.59
BLM P54132 1/20 0.59
SLC22A6 Q4U2R8 1/20 0.59
SLC22A8 Q8TCC7 1/20 0.59
MAPK1 P28482 1/20 0.57
LMNA P02545 1/20 0.55
KDR P35968 1/20 0.55
ABCB11 O95342 1/20 0.54
GLA P06280 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2351157 0.87 HSD11B1 (0.66) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL7995819 0.86 HSD11B1 (0.64) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL10958729 0.86 HSD11B1 (0.64) HSD11B1PTGS1PTGS2KDM4EUSP2
Ammonia Solution, Strong SCHEMBL10369736 0.84 HSD11B1 (0.63) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL10959470 0.83 PTGS1 (0.65) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL30218271 0.83 HSD11B1 (0.73) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL6796426 0.83 HSD11B1 (0.73) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL9983452 0.82 HSD11B1 (0.54) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL30218275 0.82 PTGS1 (0.64) HSD11B1PTGS1PTGS2KDM4EUSP2
SCHEMBL10369737 0.82 PTGS1 (0.64) HSD11B1PTGS1PTGS2KDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081652-A1 Cinnamoyl Compound and Use Thereof SHIRAKI HIROAKI 2010-04-01 US disclosed
US-20090143368-A1 Use of Cinnamoyl Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 US disclosed
EP-1857455-A1 CINNAMOYL COMPOUND AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed
EP-1857104-A1 USE OF CINNAMOYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081652-A1 Cinnamoyl Compound and Use Thereof COL2A1, MMP7, COL14A1 HSD11B1 2320/4885PTGS1 691/4885PTGS2 912/4885
US-20090143368-A1 Use of Cinnamoyl Compound COL2A1, COL1A1, SMAD2 HSD11B1 1016/4885PTGS1 268/4885PTGS2 465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.